Literature DB >> 26478219

Genetics and imaging of oligodendroglial tumors.

Jonathan R Ellenbogen1, Carol Walker1, Michael D Jenkinson1,2.   

Abstract

Oligodendroglial tumors are chemosensitive with a favorable prognosis compared with other histological subtypes. The genetic hallmark of co-deletion of 1p and 19q determines both treatment response and prognosis. While this test now forms part of routine histopathology diagnosis in many laboratories, alternative noninvasive imaging biomarkers of tumor genotype remain an attractive proposition. This review will focus on imaging biomarkers of molecular genetics in oligodendroglial tumors.

Entities:  

Keywords:  MRI; SPECT; genotype; oligoastrocytoma; oligodendroglioma

Mesh：

Year:  2015        PMID： 26478219      PMCID： PMC6082330          DOI： 10.2217/cns.15.37

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


  42 in total

1.  MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.

Authors:  Inas S Khayal; Scott R Vandenberg; Kenneth J Smith; Colleen P Cloyd; Susan M Chang; Soonmee Cha; Sarah J Nelson; Tracy R McKnight
Journal:  Neuro Oncol       Date:  2011-08-24       Impact factor: 12.300

2.  Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Authors:  M C Zlatescu; A TehraniYazdi; H Sasaki; J F Megyesi; R A Betensky; D N Louis; J G Cairncross
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

3.  Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.

Authors:  Florian Stockhammer; Ulrich-Wilhelm Thomale; Michail Plotkin; Christian Hartmann; Andreas Von Deimling
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

4.  Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.

Authors:  Natsuki Shinozaki; Yoshio Uchino; Kyosan Yoshikawa; Tomoo Matsutani; Azusa Hasegawa; Naokatsu Saeki; Yasuo Iwadate
Journal:  J Neurosurg       Date:  2011-01-07       Impact factor: 5.115

5.  Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.

Authors:  Carol Walker; Daniel G du Plessis; Diane Fildes; Brian Haylock; David Husband; Michael D Jenkinson; Kathy A Joyce; John Broome; Klaus Kopitski; Joanne Prosser; Trevor Smith; Sobhan Vinjamuri; Peter C Warnke
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

6.  MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.

Authors:  M D Jenkinson; T S Smith; K Joyce; D Fildes; D G du Plessis; P C Warnke; C Walker
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

7.  Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?

Authors:  S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-06       Impact factor: 3.825

8.  Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype.

Authors:  Michael D Jenkinson; Trevor S Smith; Andrew R Brodbelt; Kathy A Joyce; Peter C Warnke; Carol Walker
Journal:  J Magn Reson Imaging       Date:  2007-12       Impact factor: 4.813

9.  Dynamic history of low-grade gliomas before and after temozolomide treatment.

Authors:  Damien Ricard; Gentian Kaloshi; Alexandra Amiel-Benouaich; Julie Lejeune; Yannick Marie; Emmanuel Mandonnet; Michèle Kujas; Karima Mokhtari; Sophie Taillibert; Florence Laigle-Donadey; Antoine F Carpentier; Antonio Omuro; Laurent Capelle; Hugues Duffau; Philippe Cornu; Rémy Guillevin; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

10.  Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?

Authors:  C Gozé; V Rigau; L Gibert; T Maudelonde; H Duffau
Journal:  J Neurooncol       Date:  2008-08-23       Impact factor: 4.130
View more
  1 in total

1.  Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.

Authors:  Hyun Jung Yoon; Kook Jin Ahn; Song Lee; Jin Hee Jang; Hyun Seok Choi; So Lyung Jung; Bum Soo Kim; Shin Soo Jeun; Yong Kil Hong
Journal:  Neuroradiology       Date:  2017-05-26       Impact factor: 2.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.